PharmaCyte Biotech, Inc. (PMCB) Financials

PMCB Assets vs Liabilities
DateAssetsLiabilities
Oct. 31, 2023 78.9 million 20.8 million
July 31, 2023 79.9 million 20.4 million
April 30, 2023 73.3 million 586581
Jan. 31, 2023 78.0 million 827834

PMCB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Oct. 31, 2023 -2.0 million ?
July 31, 2023 342959 ?
April 30, 2023 -288388 -638072
Jan. 31, 2023 -541701 629932

PMCB Net Income

No data available :(

PMCB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Oct. 31, 2023 73.4 million - -
July 31, 2023 74.7 million - -
April 30, 2023 68.0 million - -
Jan. 31, 2023 72.6 million - -

PMCB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Oct. 31, 2023 8.8 million
July 31, 2023 12.6 million
April 30, 2023 17.8 million
Jan. 31, 2023 19.0 million

PMCB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Oct. 31, 2023 - 82033 1.1 million -
July 31, 2023 - 104483 1.7 million -
April 30, 2023 - 85874 817409 -
Jan. 31, 2023 - 45393 1.5 million -

PMCB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Oct. 31, 2023 - -
July 31, 2023 - -
April 30, 2023 - -
Jan. 31, 2023 - -

PMCB

Price: $0.70

52 week price:
0.63
1.51

Earnings Per Share: -1.11 USD

P/E Ratio: -0.64

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 64200

Market Capitalization: 5.0 million

Links: